Posted by on 7/28/2017 to General News
Today the Food and Drug Administration (FDA) announced a new comprehensive regulatory plan that will focus on nicotine in order to curb addiction and to reduce tobacco-related disease and deaths.
At the same time, FDA Commissioner Scott Gottlieb recognized that nicotine in itself is only part of the problem - it's the consumption of "the other chemical compounds in tobacco, and in the smoke created by setting tobacco on fire, that directly and primarily cause the illness and death, not the nicotine".
With this awareness of the importance of the delivery mechanism for nicotine, the FDA signaled it is moving toward a more practical harm reduction approach to vapor products by extending the deadline for premarket tobacco product applications (PMTAs) from November, 2018 to August 8, 2022. Commissioner Gottlieb noted that the FDA aims to ensure a "balance between regulation and encouraging development of innovative tobacco products that may be less dangerous than cigarettes".
This is welcome and encouraging news for both vapers and the vapor industry as a whole in the US. We hope that Commissioner Gottlieb continues to apply a more sensible, science-based approach to vapor products, so that these life-saving devices can remain on the market.
Sign Up for Our Newsletter
save 10% on your next order!